Xylem Inc. reports strong revenue, orders and earnings growth in third quarter 2017

Go back to Xylem Inc. reports strong revenue, orders and earnings growth in third quarter 2017

Xylem (XYL) PT Raised to $75 at Oppenheimer Following 3Q

November 1, 2017 9:30 AM EDT

Oppenheimer raised its price target on Xylem (NYSE: XYL) to $75.00 (from $66.00) while maintaining a Outperform rating following 3Q report. XYL reported adjusted 3Q17 EPS of $0.65, above consensus of $0.63E given strength in WI. Organic revenues increased 7% y/y despite tough comps.

The 3Q beat,... More